fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Hydrocodone bitartrate

All products: general benefit

PMS-Hydrocodone · DIN 02324253 · 1 mg/mL · oral liquid

General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
PMS-Hydrocodone · DIN 02324253 Manufacturer: Pharmascience Inc.; listing date 2012-02-29 Health Canada: Marketed since 2016-07-08 · brand PDP-HYDROCODONE · ATC R05DA03 HYDROCODONE · form Syrup · route Oral · ingredients HYDROCODONE BITARTRATE 5 MG/5ML · company Pendopharm division of pharmascience inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product record

PMS-Hydrocodone: Formulary list price $0.06 per unit (the source does not state the unit; exact figure $0.0617). What the ministry pays, not the patient.

Ministry pays: $0.0617 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02324253)

Source record
DIN 02324253: PMS-Hydrocodone Raw flags: sec3=Y Item: 480400007; group id 572; item number 1524; lccId None; manufacturer id PMS Source form: O/L; strength: 1mg/mL Recorded listing: General benefit Source prices (unrounded): $0.0617; ministry $0.0617 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02324253 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=80973
Interchangeable products
Hycodan · DIN 01916580 · not recorded
Shortage status: not checked (no credentials)

Other products in the same Health Canada class (R05DA): coverage varies; not interchangeable

  • Dextromethorphan hbr (DM-Syrup): general benefit, not a benefit
Other drugs in the same formulary class (48:04 Antitussives) and how they are covered

Matched class: 48:04 Antitussives

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): DEXTROMETHORPHAN HBR 48:04 Antitussives

DEXTROMETHORPHAN HBR

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 3mg/mL · O/L Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 48:04
Full class listing Related classes: 48:08 Expectorants Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE Adults pdp-HYDROCODONE (hydrocodone bitartrate) is indicated for the control of exhausting, non- productive cough. Geriatrics (> 65 years of age) In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, concomitant disease or other drug therapy. Pediatrics (< 18 years of age) pdp-HYDROCODONE is not indicated for use in patients younger than 18 years of age because of the risk of opioid toxicity due to the variable and unpredictable metabolism of hydrocodone to hydromorphone and because the benefits of symptomatic treatment of cough do not outweigh the risks for use of hydrocodone in these patients (see also CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, Special Populations, Pediatrics; and DOSAGE AND ADMINISTRATION). https://pdf.hres.ca/dpd_pm/00054223.PDF PM date: not printed or not captured Source product: PDP-HYDROCODONE; DIN 02324253; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.